Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Recombinant DNA")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2217

  • Page / 89
Export

Selection :

  • and

Criteria for identification and assessment of purity of proteins produced by recombinant DNABENNETT, W. F.Therapeutic agents produced by genetic engineering: Quo Vadis? Symposium. 1986, pp 111-112Conference Paper

International Meeting on Nucleic Acid Vaccines for the Prevention of Infectious DiseasesVaccine. 1997, Vol 15, Num 8, issn 0264-410X, 155 p.Conference Proceedings

Risk assessment and regulation of genetically engineered productsFRANKLIN, C. A; NESTMANN, E. R; RITTER, L et al.A.C.S. symposium series. 1987, Num 334, pp 336-351, issn 0097-6156Conference Paper

Microbial cellulases: Engineering, production and applicationsJUTURU, Veeresh; JIN CHUAN WU.Renewable & sustainable energy review. 2014, Vol 33, pp 188-203, issn 1364-0321, 16 p.Article

Crop Biotechnology for the Environment?HANSSON, Sven Ove; JOELSSON, Karin.Journal of agricultural and environmental ethics. 2013, Vol 26, Num 4, pp 759-770, issn 1187-7863, 12 p.Article

Reflections on the early development of poxvirus vectorsMOSS, Bernard.Vaccine. 2013, Vol 31, Num 39, pp 4220-4222, issn 0264-410X, 3 p.Article

Methiony human growth hormone: characteristics and analytical criteria for human pharmaceuticsFRYKLUND, L; SKOOG, B; FRIBERG, J et al.Therapeutic agents produced by genetic engineering: Quo Vadis? Symposium. 1986, pp 131-136Conference Paper

Multiplexed minipreps for rapid screening of large numbers of recombinant DNA clonesFIELD, S. J.BioTechniques. 1993, Vol 14, Num 4, pp 530-532, issn 0736-6205, 2 p.Article

The control of biological medicinal products produced by recombinant DNA technologyGRIFFITHS, E.Developments in biological standardization. 1985, Vol 59, pp 155-159, issn 0301-5149Article

Safety issues in perspectiveBRILL, W. J.A.C.S. symposium series. 1987, Num 334, pp 297-302, issn 0097-6156Conference Paper

Recombinant DNA, gene splicing as generative devices of formal languagesBONIZZONI, Paola; DE FELICE, Clelia; MAURI, Giancarlo et al.Lecture notes in computer science. 2005, pp 65-67, issn 0302-9743, isbn 3-540-26179-6, 3 p.Conference Paper

Interferons: what future?SCOTT, G. M.Trends in biotechnology (Library edition). 1986, Vol 4, Num 4, pp 78-79, issn 0167-9430Article

Strategie ricombinati per il targetins molecolare = Technologie de l'ADN recombinant pour l'adressage moléculaire = Recombinant technology for molecular targetingMARTINI, D; SORIA, M.Chimica oggi. 1987, Num 12, pp 49-51, issn 0392-839XArticle

Plasmid DNA-recombinant Opc protein complexes for nasal DNA immunizationMUSACCHIO, Alexis; QUINTANA, Diogenes; HERRERA, Antonieta M et al.Vaccine. 2001, Vol 19, Num 27, pp 3692-3699, issn 0264-410XArticle

Recombinant DNA technology in Ghana ― report on a workshop held in August 1993. A case study for molecular biology in a developing countryPARISH, J. H.Biochemical education. 1994, Vol 22, Num 2, pp 84-85, issn 0307-4412Article

Consecutive DNA terminator sequencing by using enzymatically generated primersSPEEK, M; ILVES, H; LIND, A et al.Analytical biochemistry. 1986, Vol 158, Num 2, pp 242-249, issn 0003-2697Article

Restriction enzymesROSS, D. W.Archives of pathology & laboratory medicine (1976). 1990, Vol 114, Num 8, issn 0363-0153, p. 906Article

Crystallization of recombinant human interleukin-2MORIYA, N; YAMADA, T; KATO, K et al.Bio/technology (New York, N.Y. 1983). 1986, Vol 4, Num 10, pp 904-905, issn 0733-222XArticle

Contribution to hepatitis B preventionSTEPHENNE, J.Vaccine. 1992, Vol 10, Num 13, pp 900-903, issn 0264-410XConference Paper

The construction and use of cloning vectorsMULLANY, P; WREN, B; WILKS, M et al.Society for Applied Bacteriology. Technical Series. 1991, Vol 28, pp 25-36, issn 0583-8924Article

Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virusBROEKHUIJSEN, M. P; BLOM, T; VAN RIJN, J et al.Gene (Amsterdam). 1986, Vol 49, Num 2, pp 189-197, issn 0378-1119Article

A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in miceAMIT KUMAR SINGH; KINGSTON, Joseph Jeyabalaji; HARISHCHANDRA SRIPATHY MURALI et al.Vaccine. 2014, Vol 32, Num 11, pp 1233-1239, issn 0264-410X, 7 p.Article

Enhanced production of astaxanthin in Paracoccus sp. strain N-81106 by using random mutagenesis and genetic engineeringIDE, Teruhiko; HOYA, Megumi; TANAKA, Toru et al.Biochemical engineering journal. 2012, Vol 65, pp 37-43, issn 1369-703X, 7 p.Article

Overproduction of recombinant proteins in plantsEGELKROUT, Erin; RAJAN, Vidya; HOWARD, John A et al.Plant science (Limerick). 2012, Vol 184, pp 83-101, issn 0168-9452, 19 p.Article

Characterization of a thermophilic L-arabinose isomerase from Thermoanaerobacterium saccharolyticum NTOU1HUNG, Xing-Guang; TSENG, Wen-Chi; LIU, Shiu-Mei et al.Biochemical engineering journal. 2014, Vol 83, pp 121-128, issn 1369-703X, 8 p.Article

  • Page / 89